Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 85, Issue 5, Pages 843-853
Publisher
Springer Science and Business Media LLC
Online
2020-03-30
DOI
10.1007/s00280-020-04061-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bromodomain and Extraterminal Domain Inhibition Synergizes with WEE1‐Inhibitor AZD1775 Effect by Impairing Non‐Homologous End Joining and Enhancing DNA Damage in Non‐Small Cell Lung Cancer
- (2019) Yuta Takashima et al. INTERNATIONAL JOURNAL OF CANCER
- Mitochondrial Involvement in Cisplatin Resistance
- (2019) Veronica Cocetta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune checkpoint blockade in small cell lung cancer
- (2019) Rebecca Y. Tay et al. LUNG CANCER
- The immunoproteasome and thymoproteasome: functions, evolution and human disease
- (2018) Shigeo Murata et al. NATURE IMMUNOLOGY
- Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)
- (2017) Susanne M. Arnold et al. INVESTIGATIONAL NEW DRUGS
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
- (2017) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis
- (2017) Motofumi Suzuki et al. Translational Oncology
- Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
- (2016) Denise Niewerth et al. Journal of Hematology & Oncology
- Mechanisms of Selective Autophagy
- (2016) Gabriele Zaffagnini et al. JOURNAL OF MOLECULAR BIOLOGY
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
- (2016) Lisa Zhang et al. Oncotarget
- Expression of immunoproteasome genes is regulated by cell-intrinsic and –extrinsic factors in human cancers
- (2016) Alexandre Rouette et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines
- (2014) Denise Niewerth et al. Journal of Hematology & Oncology
- A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors
- (2013) Kyriakos P. Papadopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins
- (2013) James A. Nathan et al. CELL
- Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors
- (2013) D. Niewerth et al. HAEMATOLOGICA
- The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells
- (2012) M. Wangpaichitr et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells
- (2011) Ye Xu et al. CANCER LETTERS
- The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes
- (2010) Andrew M. Pickering et al. BIOCHEMICAL JOURNAL
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
- (2010) Anamaria Brozovic et al. CRITICAL REVIEWS IN TOXICOLOGY
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
- (2008) Antonia Busse et al. CANCER
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now